Frontiers in Clinical Drug Research - Anti-Cancer Agents
View Sample
To Avail the Discount Please Click Below.
DEAL OF THE DAY:   US $31.2US $3920%

Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 1

eBook: US $39 Special Offer (PDF + Printed Copy): US $138
Printed Copy: US $119
Library License: US $156
ISSN: 2215-0803 (Online)
ISBN: 978-1-60805-799-3 (Print)
ISBN: 978-1-60805-798-6 (Online)
Year of Publication: 2014
DOI: 10.2174/97816080579861130101


Frontiers in Clinical Drug Research - Anti-Cancer Agents should prove to be a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field. The chapters in this volume have been written by leading experts from the field.

The contents of this book include new approaches to cancer therapy, treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors, targeting key signaling pathways in pediatric brain tumors, current status of cladribine in lymphoid and myeloid malignancies, natural anti-cancer products and the mechanisms of telomere and telomerase regulation in hematologic malignancies.

The eBook series is essential to all scientists involved in clinical drug research who wish to keep abreast of rapid and important developments in the field. The readers will find these reviews valuable and will certainly trigger further research in the pharmaceutical development of anti-cancer agents.


- Pp. i-ii (2)
Download Free

List of Contributors

- Pp. iii-iv (2)
Download Free

A New Approach to Cancer Therapy: The Tumor Microenvironment as Target

- Pp. 3-68 (66)
Reto A. Schwendener, Sibel Mete
View Abstract

The Current Status of Cladribine in the Treatment of Lymphoid and Myeloid Malignancies

- Pp. 69-114 (46)
Tadeusz Robak, Pawel Robak
View Abstract

The Mechanisms of Telomere and Telomerase Regulation in Hematologic Malignancies

- Pp. 115-183 (69)
Kiyotaka Kawauchi, Masaharu Akiyama, Osamu Yamada
View Abstract

The Treatment of Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

- Pp. 184-238 (55)
Vera Hirsh
View Abstract

Targeting Key Signaling Pathways in Pediatric Brain Tumors

- Pp. 239-267 (29)
Fernanda I. Arnaldez, Katherine E. Warren
View Abstract

Natural Anti-Cancer Products

- Pp. 268-338 (71)
Shao-Zhi Fu, Ling-Lin Yang, Jing-Bo Wu
View Abstract


- Pp. 339-358 (20)
Download Free


.Therapeutic Nanocarriers in Cancer Treatment: Challenges and
                    Future Perspective.
.Therapeutic Drug Targets and Phytomedicine For Triple Negative
                    Breast Cancer.
.Current Cancer Biomarkers.
.Neoplasia and Fertility.